EnteroMedics (ETRM -9.1%) is down after closing out its secondary offering of 8.8M common shares...

|About: EnteroMedics Inc. (ETRM)|By:, SA News Editor

EnteroMedics (ETRM -9.1%) is down after closing out its secondary offering of 8.8M common shares and 1.76M warrants. It will use the proceeds from the sale to help fund the development of its Maestro RC System, which is used in the treatment of obesity, diabetes and hypertension.